These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 4150479)

  • 21. Structure-selectivity relationships of beta-adrenoceptor antagonists in cats.
    Zakhari S
    Eur J Pharmacol; 1974 Nov; 29(1):22-9. PubMed ID: 4154860
    [No Abstract]   [Full Text] [Related]  

  • 22. [Myocardial consumption of free fatty acids and carbohydrates following treatment with a new beta-blockader (1-o-methoxyphenoxy-3-isopropylamino-2-propanol HC1) D 1601].
    Marchetti G; Merlo L; Noseda V
    Boll Soc Ital Cardiol; 1973; 18(7):672-5. PubMed ID: 4157148
    [No Abstract]   [Full Text] [Related]  

  • 23. [Clinical pharmacology of trimepranol (pharmacokinetic informations and effects on heart rate in healthy individuals)].
    Mayer O; Petrlík M; Vitous J; Cepelák V
    Vnitr Lek; 1976 Nov; 22(11):1102-9. PubMed ID: 12612
    [No Abstract]   [Full Text] [Related]  

  • 24. [Structure-activity relationship of phenoxyalkanolamine derivatives with selective beta 1-receptor blocking action].
    Femmer K
    Pharmazie; 1975 Oct; 30(10):638-42. PubMed ID: 687
    [No Abstract]   [Full Text] [Related]  

  • 25. Effects of SD/1601 on tolerance to exercise in patients with angina.
    Maggi A; Mariani G; Tettamanti R; Tallone G
    G Ital Cardiol; 1975; 5(1):142-8. PubMed ID: 235477
    [No Abstract]   [Full Text] [Related]  

  • 26. Cardiovascular effects of tolamolol (UK-6558), a new beta-adrenoreceptor blocking drug, in pinealectomized hypertensive rats.
    Karppanen H; Lahovaara S; Mattila MJ
    Ann Med Exp Biol Fenn; 1973 Mar; 51(3):104-11. PubMed ID: 4149365
    [No Abstract]   [Full Text] [Related]  

  • 27. Effects of beta adrenergic blocking agents on plasma renin activity in the conscious rabbit.
    Weber MA; Thornell IR; Stokes GS
    J Pharmacol Exp Ther; 1974 Jan; 188(1):234-40. PubMed ID: 4148935
    [No Abstract]   [Full Text] [Related]  

  • 28. Pharmacological properties of a new beta-blocking agent (1-isopropylamino-3-(2-methyl-3-nitrophenoxy)-propan-2-ol).
    Michalska Z; Robak J; Kostka-Trabka E; Grodzińska L; Górka Z; Gryglewski R
    Folia Biol (Krakow); 1974; 22(2):217-28. PubMed ID: 4151603
    [No Abstract]   [Full Text] [Related]  

  • 29. [Effect of the beta-adrenergic blocking agent bupranolol on the plasma renin activity in normotensive rats].
    Placheta P; Singer E; Kraupp O
    Arzneimittelforschung; 1977; 27(11):2063-6. PubMed ID: 23790
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of beta-adrenolytic properties of N,N'-bis-(3-(p-methoxyphenoxy)-2-hydroxypropyl)-ethylenediamine and its N,N'-dimethyl derivative.
    Robak J; Grodzińska L
    Pol J Pharmacol Pharm; 1973; 25(3):253-7. PubMed ID: 4150018
    [No Abstract]   [Full Text] [Related]  

  • 31. Action of clonidine on baroreceptor reflexes in conscious dogs.
    Walland A; Kobinger W; Csongrady A
    Eur J Pharmacol; 1974 May; 26(2):184-90. PubMed ID: 4152757
    [No Abstract]   [Full Text] [Related]  

  • 32. [Pharmacology of 1-phenylaminoethylamino-3-(phenoxy)propanol derivatives with beta-adrenergic action].
    Femmer K; Heer S; Poppe H
    Pharmazie; 1983 Jun; 38(6):409-14. PubMed ID: 6136994
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of beta-adrenergic blocking activities of propranolol, isopropylmethoxamine, sotalol, practolol, alprenolol, pindolol, oxprenolol and D-32 in the atria and trachea of the guinea-pig.
    Horii D; Kawada T; Takeda K; Imai S
    Arzneimittelforschung; 1974 Sep; 24(9):1275-7. PubMed ID: 4154764
    [No Abstract]   [Full Text] [Related]  

  • 34. Renin release, saralasin and the vasodilator-beta-blocker drug interaction in man.
    Pettinger WA; Mitchell HC
    N Engl J Med; 1975 Jun; 292(23):1214-7. PubMed ID: 236513
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Esmolol for potentiation of nitroprusside-induced hypotension: impact on the cardiovascular, adrenergic, and renin-angiotensin systems in man.
    Edmondson R; Del Valle O; Shah N; Wong G; Dwyer D; Matarazzo D; Thorne A; Coffey C; Bedford R
    Anesth Analg; 1989 Aug; 69(2):202-6. PubMed ID: 2569849
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adrenergic antagonists, and a possible link between the increase in cyclic adenosine 3',5'-monophosphate and DNA synthesis during liver regeneration.
    MacManus JP; Braceland BM; Youdale T; Whitfield JF
    J Cell Physiol; 1973 Oct; 82(2):157-64. PubMed ID: 4148138
    [No Abstract]   [Full Text] [Related]  

  • 37. [The effect of aryloxyaminopropanol substances on the photosynthetic activity of chloroplasts in Spinacia oleracea L].
    Cizmáriková R; Kráĺová K; Sersen F
    Ceska Slov Farm; 2000 Jan; 49(1):45-7. PubMed ID: 10953443
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of adrenergic beta-blockade using trimepranol on glucose, insulin, somatotropin and nonesterified fatty acids in the blood of women with diabetes mellitus].
    Felt V; Nedvídkrová J; Hortová O
    Vnitr Lek; 1974 Nov; 20(11):1050-4. PubMed ID: 4155166
    [No Abstract]   [Full Text] [Related]  

  • 39. Pharmacokinetics and biopharmaceutics of some adrenergic beta-receptor antagonists with special emphasis on alprenolol and metoprolol.
    Regårdh CG
    Acta Pharmacol Toxicol (Copenh); 1975; 37(1):1-39. PubMed ID: 237402
    [No Abstract]   [Full Text] [Related]  

  • 40. Cardiac action of carazolol and methypranol in comparison with other beta-receptor blockers.
    Bartsch W; Dietmann K; Leinert H; Sponer G
    Arzneimittelforschung; 1977; 27(5):1022-6. PubMed ID: 18157
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.